menu
    • menu

    Company profile for Infant Bacterial Therapeutics

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    IBT is a pharmaceutical company with its registered office in Stockholm with a vision to develop drugs influencing the human infant microbiome, and thereby prevent or treat rare diseases affecting premature infants. IBT is currently developing its lead drug candidate IBP-9414, to prevent NEC and improve feeding tolerance in premature infants. IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacter...
    IBT is a pharmaceutical company with its registered office in Stockholm with a vision to develop drugs influencing the human infant microbiome, and thereby prevent or treat rare diseases affecting premature infants. IBT is currently developing its lead drug candidate IBP-9414, to prevent NEC and improve feeding tolerance in premature infants. IBP-9414 contains the active compound Lactobacillus reuteri, which is a human bacterial strain naturally present in breast milk.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Infant Bacterial TherapeuticsSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Bryggargatan 10 111 21 Stockholm
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://ibtherapeutics.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    New number of shares and votes in IBT
    New number of shares and votes in IBT

    31 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/31/2714590/0/en/New-number-of-shares-and-votes-in-IBT.html

    GLOBENEWSWIRE
    31 Jul 2023
    Share Share
    Additional Infant Bacterial product receives FDA orphan drug designation
    Additional Infant Bacterial product receives FDA orphan drug designation

    03 Jul 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/07/03/2698649/0/en/Additional-Infant-Bacterial-Therapeutics-product-receives-FDA-orphan-drug-designation.html

    GLOBENEWSWIRE
    03 Jul 2023
    Share Share
    New patent for Infant Bacterial Therapeutics has been approved in Europe
    New patent for Infant Bacterial Therapeutics has been approved in Europe

    15 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/15/2689019/0/en/New-patent-for-Infant-Bacterial-Therapeutics-has-been-approved-in-Europe.html

    GLOBENEWSWIRE
    15 Jun 2023
    Share Share
    IBT publishes prospectus
    IBT publishes prospectus

    13 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/13/2686920/0/en/IBT-publishes-prospectus.html

    GLOBENEWSWIRE
    13 Jun 2023
    Share Share
    Extraordinary General Meeting of Infant Bacterial Therapeutics
    Extraordinary General Meeting of Infant Bacterial Therapeutics

    09 Jun 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/06/09/2685361/0/en/Extraordinary-General-Meeting-of-Infant-Bacterial-Therapeutics.html

    GLOBENEWSWIRE
    09 Jun 2023
    Share Share
    Notice of Extraordinary General Meeting of Infant Bacterial Therapeutics
    Notice of Extraordinary General Meeting of Infant Bacterial Therapeutics

    16 May 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/05/16/2670518/0/en/Notice-of-Extraordinary-General-Meeting-of-Infant-Bacterial-Therapeutics.html

    GLOBENEWSWIRE
    16 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search